PLEASE NOTE: Samples and accompanying relevant patient/ isolate data maybe referred for confirmatory or further laboratory testing to Reference laboratories. Relevant Public Health departments may also be notified IF a notifiable disease is identified under the Infectious Diseases (Amendment) Regulations 2020 (S.I. No. 53/2020).
Preparation of patient: Collect specimens before antimicrobial therapy where possible.
Precautions: National Guidelines issued by the Department of Health, December 2013, recommend that swabs from the anterior nares, perineum or groin, throat, catheter specimen of urine (CSU), sputum if productive cough and any skin lesions (e.g. surgical site, PEG tube site) should be obtained for screening purposes. Additional samples to diagnose infection (e.g. blood, vascular catheter tip) should be taken as clinically indicated.
For previously MRSA positive patients who have undergone decolonisation, three negative follow-up samples at least 48 hours apart are required for the patient to be considered as successfully decolonised.
If processing is delayed, refrigeration is preferable to storage at ambient temperature. Delays of over 48hr are undesirable.